Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Surg Oncol ; 44(2): 243-250, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29269109

ABSTRACT

BACKGROUND: To define the association between an appropriate pre-operative workup (pre-operative advanced imaging studies, diagnostic biopsy) and incomplete soft tissue sarcoma (STS) excision. PATIENTS AND METHODS: This was a retrospective review of 397 consecutive patient records (2000-2008), looking at primary site advanced imaging (MRI or CT) and diagnostic biopsy procedures completed prior to the initial attempt at definitive surgical excision. Downstream effects of an inadequate pre-operative workup were also evaluated, including time to referral to a sarcoma multi-disciplinary care team and perceived alteration of surgical care in order to obtain a complete excision of the altered sarcoma bed. RESULTS: Thirty-eight percent (149/397) of soft tissue sarcomas identified underwent an incomplete excision prior to referral. A significant difference in the incidence of pre-operative primary site advanced imaging (91% vs. 42%, p < 0.001) and a pre-operative diagnostic biopsy (85% vs. 16%, p < 0.001) was found between the wide excision group and incomplete excision groups. Pre-operative biopsy (p < 0.001), tumor size >5 cm (p < 0.001), and a referral from an orthopaedic surgeon (p < 0.02) were all associated with reduced risk of incomplete excision in multivariate analysis. Seventy-four percent of patients in the incomplete excision group required an alteration in their definitive wide margin surgical resection, including rotational muscle flap coverage (37%), free flap coverage (11%), or amputation (11%). CONCLUSION: A minority of patients referred following incomplete excision of a STS had undergone an appropriate pre-operative workup prior to referral, leading to increased long-term morbidity following definitive re-excision. Education efforts to heighten awareness of suspicious soft tissue lesions remain vital.


Subject(s)
Extremities/diagnostic imaging , Preoperative Care/methods , Sarcoma/diagnostic imaging , Soft Tissue Neoplasms/diagnostic imaging , Adult , Aged , Amputation, Surgical , Case-Control Studies , Chemotherapy, Adjuvant , Databases, Factual , Extremities/pathology , Extremities/surgery , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Multivariate Analysis , Neoplasm Grading , Neoplasm, Residual , Orthopedic Surgeons , Patient Care Team , Radiotherapy, Adjuvant , Referral and Consultation , Retrospective Studies , Sarcoma/pathology , Sarcoma/surgery , Soft Tissue Neoplasms/pathology , Soft Tissue Neoplasms/surgery , Surgical Flaps , Time Factors , Tomography, X-Ray Computed , Tumor Burden
2.
Ann Oncol ; 25(3): 725-729, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24504446

ABSTRACT

BACKGROUND: Spousal support has been hypothesized as providing important psychosocial support for patients and as such has been noted to provide a survival advantage in a number of chronic diseases and cancers. However, the specific effect of marital status on survival in soft tissue sarcomas (STSs) of the extremity has not been explored in detail. PATIENTS AND METHODS: A total of 7384 patients were evaluated for this study using a Surveillance, Epidemiology, and End Results (SEER) registry query for patients over 20 years old with extremity STS diagnosed between 2004 and 2009. Survival outcomes were analyzed using Gray's test after patients were stratified by marital status. The Fine and Gray model, a multivariable regression model, was used to assess whether marital status was an independent predictor of sarcoma specific death. Statistical significance was maintained at P < 0.05. RESULTS: Analysis of the SEER database showed that single patients were more likely to die of their STS and at a faster rate than married patients. No differences were noted in tumor size and tumor site on presentation between married and single patients. However, single patients presented with higher grade tumors more frequently (P = 0.013), received less radiotherapy (P < 0.001), and had less surgery carried out (P < 0.001), compared with their married peers. Regression analysis showed that after accounting for tumor size, grade, site, histology, use of radiotherapy, age, gender, region where the patients were from, and income, being single continued to serve as an independent predictor of sarcoma-specific death; P < 0.0001. CONCLUSION: Overall survival is worse for single patients, when compared with married patients, with STS. Single patients do not undergo surgical resection or receive radiation therapy as frequently as their married counterparts. Social support systems and barriers to care should be evaluated at time of diagnosis and addressed in single patients to potentially improve survival outcomes.


Subject(s)
Extremities/pathology , Marital Status , Sarcoma/mortality , Aged , Caregivers , Female , Humans , Male , Middle Aged , SEER Program , Sarcoma/radiotherapy , Sarcoma/surgery , Social Support , Spouses , Survival Rate
3.
Eur J Surg Oncol ; 39(12): 1325-31, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24176674

ABSTRACT

AIMS: Recurrent breast carcinoma with brachial plexus involvement is often misinterpreted as a radiation- or chemotherapy-induced brachial plexopathy. We review a case series of 4 patients at our institution within a 1-year period, and describe their diagnostic workup and treatment with a palliative periscapular amputation. Our aim is to describe this entity, indications and benefits of this procedure, when required for progressive disease, with the goal of raising a collective index of suspicion to aid in earlier diagnosis. METHODS: Four patients with recurrent axillary breast cancer and symptoms consistent with a brachial plexopathy were prospectively collected over a 1-year period. A Pubmed search was conducted; pertinent articles were reviewed and reported. RESULTS: Patients presented with intractable pain and flaccid paralysis of the ipsilateral limb. All had been previously treated with surgical resection, axillary lymph node dissection, chemotherapy, and radiation therapy. Average time from breast surgery to presentation was 78.75 months (range 11-216 months.) Workup included MRI and biopsy to confirm recurrence. Periscapular amputation was performed for each patient, all of who experienced subjective pain relief postoperatively. Three of the 4 patients are still living; one patient died of disease. CONCLUSION: Breast cancer survivors presenting with a brachial plexopathy should raise suspicion for recurrent disease. Close evaluation with MRI is the best first step in diagnosis. Although periscapular amputation is an aggressive surgical treatment, it is an acceptable option when disease has progressed to neurovascular involvement and a functionless limb.


Subject(s)
Brachial Plexus Neuropathies/surgery , Breast Neoplasms/therapy , Carcinoma/therapy , Lymph Node Excision , Palliative Care , Peripheral Nervous System Neoplasms/surgery , Amputation, Surgical , Axilla , Brachial Plexus Neuropathies/diagnosis , Brachial Plexus Neuropathies/etiology , Breast Neoplasms/pathology , Carcinoma/secondary , Chemotherapy, Adjuvant , Female , Humans , Lymphatic Metastasis , Magnetic Resonance Imaging , Middle Aged , Pain, Intractable/etiology , Pain, Intractable/surgery , Peripheral Nervous System Neoplasms/complications , Peripheral Nervous System Neoplasms/secondary , Radiotherapy, Adjuvant , Retrospective Studies , Upper Extremity/surgery
4.
Eur J Surg Oncol ; 38(12): 1178-83, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22985713

ABSTRACT

To determine if amputation increases survival when compared to limb salvage surgery in patients with a soft tissue sarcoma (STS) of the extremity when there is often a misconception among physicians and patients that ablative surgery eliminates local recurrence and increases overall survival. This retrospective cohort study assessed 278 patients with STS and compared 18 patients who had undergone amputations for soft tissue sarcomas of the extremities to a comparative cohort of 260 patients who underwent limb salvage surgery during the same time period. Our limb salvage surgery (LSS) rate was 94% overall for soft tissue sarcomas with a median follow-up of 3.1 years. Patients undergoing amputations either had tumors that involved a critical neurovascular bundle (in particular nerve rather than vessel resection was more responsible for a decision toward ablation), or underlying bone or had neoplasms whose large size would require such an enormous resection that a functional limb would not remain. In comparing prognostic effects, mainly death due to sarcoma, distant metastasis and local recurrence, it was found that there was no statistically significant difference between patients undergoing amputation to those undergoing limb salvage surgery (p > 0.05). While amputations do not increase overall survival in soft tissue sarcomas of the extremity as compared to LSS, they are still a valuable option in a surgeon's arsenal. In particular, amputations can provide improved local control and symptomatic treatment in patients who might not be candidates for limb salvage surgery.


Subject(s)
Amputation, Surgical , Extremities/surgery , Sarcoma/surgery , Soft Tissue Neoplasms/surgery , Adult , Aged , Disease-Free Survival , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Retrospective Studies , Sarcoma/mortality , Soft Tissue Neoplasms/mortality , Survival Rate/trends , Time Factors , United States/epidemiology
5.
Cancer Res ; 61(15): 5857-60, 2001 Aug 01.
Article in English | MEDLINE | ID: mdl-11479226

ABSTRACT

To identify genes that are differentially up-regulated in prostate cancer of transgenic adenocarcinoma mouse prostate (TRAMP) mice, we subtracted cDNA isolated from mouse kidney and spleen from cDNA isolated from TRAMP-C1 cells, a prostate tumor cell line derived from a TRAMP mouse. Using this strategy, cDNA clones that were homologous to human six-transmembrane epithelial antigen of the prostate (STEAP) and prostate stem cell antigen (PSCA) were isolated. Mouse STEAP (mSteap) is 80% homologous to human STEAP at both the nucleotide and amino acid levels and contains six potential membrane-spanning regions similar to human STEAP. Mouse PSCA (mPsca) shares 65% homology with human PSCA at the nucleotide and amino acid levels. mRNA expression of mSteap and mPsca is largely prostate-specific and highly detected in primary prostate tumors and metastases of TRAMP mice. Both mSteap and mPsca map to chromosome 5. Another known gene coding for mouse prostate-specific membrane antigen (mPsma) is also highly expressed in both primary and metastatic lesions of TRAMP mice. These results indicate that the TRAMP mouse model can be used to effectively identify genes homologous to human prostate-specific genes, thereby allowing for the investigation of their functional roles in prostate cancer. mSteap, mPsca, and mPsma constitute new tools for preventative and/or therapeutic vaccine construction and immune monitoring in the TRAMP mouse model that may provide insights into the treatment of human prostate cancer.


Subject(s)
Adenocarcinoma/genetics , Antigens, Neoplasm/genetics , Antigens, Surface/genetics , Prostatic Neoplasms/genetics , Adenocarcinoma/immunology , Amino Acid Sequence , Animals , Antigens, Neoplasm/biosynthesis , Antigens, Neoplasm/immunology , Antigens, Surface/biosynthesis , Carboxypeptidases/biosynthesis , Carboxypeptidases/genetics , Disease Models, Animal , GPI-Linked Proteins , Gene Expression , Glutamate Carboxypeptidase II , Humans , Male , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Molecular Sequence Data , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Oxidoreductases , Prostatic Neoplasms/immunology , Sequence Homology, Amino Acid
6.
Cytokine ; 6(1): 102-10, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8003628

ABSTRACT

Transient expression of interleukin 2 (IL-2) in activated T lymphocytes may be due to transcriptional and post-transcriptional regulation. As incubation of lymphocytes with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) prior to mitogenic stimulation results in decreased levels of IL-2 mRNA, we asked if IL-2 mRNA stability was affected. We found that in TPA-treated cells, IL-2 mRNA was degraded more rapidly than in untreated ones whether the mitogenic stimulus was Concanavalin A (Con A), Con A plus TPA, or TPA plus ionomycin. The degradation was blocked if the TPA pre-incubation included cycloheximide. In contrast, when TPA was included as a co-mitogen, i.e. added at the same time as the mitogen, the IL-2 mRNA levels and stability significantly increased. Compared to the levels found in Con A stimulated cells, TPA plus Con A increased IL-2 mRNA levels by as much as 20-fold and the half-life by 5-fold. TPA plus ionomycin increased the message levels at least 100-fold and half-life by nearly 10-fold. These effects on IL-2 mRNA were not general because IL-2 receptor mRNA stability was not changed even though it also is transiently expressed during the course of lymphocyte activation.


Subject(s)
Gene Expression , Interleukin-2/biosynthesis , Lymphocyte Activation , Lymphocytes/metabolism , RNA, Messenger/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Animals , Blotting, Northern , Cattle , Cell Survival/drug effects , Cells, Cultured , Concanavalin A , Cycloheximide/pharmacology , Dactinomycin/pharmacology , Gene Expression/drug effects , Half-Life , Ionomycin/pharmacology , Kinetics , Lymph Nodes/immunology , Lymphocytes/drug effects , Lymphocytes/immunology , RNA, Messenger/biosynthesis
7.
J Histochem Cytochem ; 30(5): 413-7, 1982 May.
Article in English | MEDLINE | ID: mdl-7042816

ABSTRACT

Paraffin sections of 95% ethanol-fixed uterine cervices from adult, cycling rats and from human patients undergoing elective hysterectomy were immunostained by the peroxidase-antiperoxidase technique after exposure to antisera against fibronectin. Light microscopic study of uterine cervical stroma from both species showed an irregular distribution of fibronectin between compactly arranged collagenous fibers and a more uniform deposition around scattered bundles of smooth muscle fibers. In loosely arranged areas of stromal collagen, fibronectin was found in a filamentous, occasionally punctate, distribution. There was moderate to heavy staining with immunoperoxidase for fibronectin in the regions of the basement membrane underlying cervical epithelia and in the connective tissue stroma immediately subjacent to the basement membrane. Fibronectin was also present in the walls of most blood vessels and in the connective tissue investments of peripheral nerve fascicles. These findings suggest that fibronectin may be another component of extracellular matrix in the uterine cervical wall of non-gravid human subjects and rats in addition to collagen and glycosaminoglycans.


Subject(s)
Cervix Uteri/cytology , Fibronectins/analysis , Animals , Basement Membrane/cytology , Female , Humans , Immunoenzyme Techniques , Rats , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...